5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy
Open accessThe DOI matches its Crossref record; 170 of the 180 references it cites were found in a registry or an index; 75 of the 205 sources its claims cite were checked for support.
Abstract
5-Aminolevulinic acid (ALA) is a naturally occurring amino acid synthesized in all nucleated mammalian cells. As a porphyrin precursor, ALA is metabolized in the heme biosynthetic pathway to produce protoporphyrin IX (PpIX), a fluorophore and photosensitizing agent. ALA administered exogenously bypasses the rate-limit step in the pathway, resulting in PpIX accumulation in tumor tissues. Such tumor-selective PpIX disposition following ALA administration has been exploited for tumor fluorescence diagnosis and photodynamic therapy (PDT) with much success. Five ALA-based drugs have now received worldwide approval and are being used for managing very common human (pre)cancerous diseases such as actinic keratosis and basal cell carcinoma or guiding the surgery of bladder cancer and high-grade gliomas, making it the most successful drug discovery and development endeavor in PDT and photodiagnosis. The potential of ALA-induced PpIX as a fluorescent theranostic agent is, however, yet to be fully fulfilled. In this review, we would like to describe the heme biosynthesis pathway in which PpIX is produced from ALA and its derivatives, summarize current clinical applications of ALA-based drugs, and discuss strategies for enhancing ALA-induced PpIX fluorescence and PDT response. Our goal is two-fold: to highlight the successes of ALA-based drugs in clinical practice, and to stimulate the multidisciplinary collaboration that has brought the current success and will continue to usher in more landmark advances.
Overview
CoChat Summary
## TL;DR
This review explains how 5-aminolevulinic acid (ALA) is converted to protoporphyrin IX (PpIX), and how that PpIX enables both fluorescence-guided tumor diagnosis and photodynamic therapy (PDT). It argues that ALA-based drugs are already highly successful in actinic keratosis, basal cell carcinoma, bladder cancer, and high-grade gliomas, while additional protocol, device, and pathway-targeting refinements may further improve outcomes.
## Key findings
- Five ALA-based drugs had received worldwide approval by the time of the review, and the paper identifies ALA-based therapy as “the most successful drug discovery and development endeavor in PDT and photodiagnosis.”
- For high-grade glioma, the paper reports that a randomized phase III trial found fluorescence-guided resection achieved more gross total resection than white-light surgery: 65% vs 36%, with higher 6-month progression-free survival (41% vs 21%).
- For bladder cancer, the paper reports that in 68 patients, ALA-induced fluorescence had 100% sensitivity and 68.5% specificity for tumor detection, and that fluorescence cystoscopy revealed 26 cancerous or precancerous lesions out of 299 biopsies that white light would have missed.
- For actinic keratosis and superficial BCC, the paper reports multiple clinical results, including 72% complete response at 12 weeks for head actinic keratosis with ALA + blue light, up to 91% complete response for AK and 97% for BCC with MAL-PDT, and about 85% lesion clearance with BF-200 ALA and a simulated daylight system.
- The review highlights enhancement strategies that can raise PpIX fluorescence or PDT response, including optimizing dose/timing, fractionated illumination, daylight or simulated daylight systems, iron chelation, FECH inhibition, ABCG2 inhibition, pro-survival pathway inhibition, and immune checkpoint blockade.
## Methods
- Narrative review of the ALA/PpIX heme biosynthesis pathway, therapeutic PDT mechanisms, intraoperative fluorescence imaging, and strategies to enhance ALA-PpIX fluorescence and ALA-PDT response.
- Uses published clinical trials, randomized trials, multicenter studies, and preclinical cell/animal studies as the evidence base; no new original patient cohort is reported in the paper.
- Main analysis is qualitative synthesis, organizing findings by mechanism and application area (actinic keratosis, BCC, bladder cancer, glioma), and comparing protocols, devices, and combination strategies.
## Limitations
- The paper states that the potential of ALA-induced PpIX as a fluorescent theranostic agent is “yet to be fully fulfilled.”
- It explicitly notes that whether targeting PpIX bioconversion and efflux will produce clinical benefit “remains to be seen,” and that clinical trials are needed to test whether combined fluorescence-guided surgery plus PDT improves survival beyond current standard practice.
- Evident from the text: much of the enhancement evidence comes from in vitro or animal studies, and several proposed inhibitors or protocol refinements are not yet clinically validated or are not available for clinical use.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
49 Valid · 5 Not valid · 87 Not checked · 18 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Probe-based sectioning microscopes with red light illumination are able to provide high-resolution quantitative imaging of PpIX even in deep tissues [81].”
§ 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy > 6. Strategies for Enhancing ALA-PpIX Fluorescence and ALA-PDT Response > 6.2. Device Improvements & Developments
What the sources say
- Disputedcites [81] Wei, 2019, Visualization Technologies for 5-ALA-Based Fluorescence-Guided Surgeries, J. Neurooncol. sourceExperimental — accuracy not yet measured
The Deep-tissue imaging techniques section (page not provided) says high-resolution imaging is typically limited to about 100 microns of tissue depth. It attributes quantitative PpIX imaging several millimeters deep with red-light excitation to wide-field systems with about 1 mm spatial resolution, not to high-resolution probe-based sectioning microscopes. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Photoactivation of endogenous PpIX induced by ALA results in the elimination of erythroleukemia cells as Malik et al. showed in 1987, which is the first report of using ALA-PDT for cell inactivation [5].”
§ 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy > 3. ALA as a Therapeutic Agent for PDT
What the sources say
- Partly supportedcites [5] Malik, 1987, Destruction of Erythroleukaemic Cells by Photoactivation of Endogenous Porphyrins, Br. J. Cancer sourceExperimental — accuracy not yet measured
The Summary (p. 589) reports that ALA-treated Friend erythroleukaemia cells accumulated protoporphyrin and that irradiation disintegrated more than 95% of cells. The Discussion also reports photoinactivation, but says both uroporphyrin and protoporphyrin may act as photosensitizers; our copy does not establish the citing sentence’s additional claim that this was the first report of ALA-PDT for cell inactivation. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As a porphyrin precursor, ALA is metabolized in the heme biosynthetic pathway to produce protoporphyrin IX (PpIX), a fluorophore and photosensitizing agent.”
§ 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy > Abstract
What the sources say
- Supportedcites [8] Ajioka, 2006, Biosynthesis of Heme in Mammals, Biochim. Biophys. Acta (BBA)-Mol. Cell Res. source
Section 1.1 describes ALA entering the heme biosynthetic pathway, and section 1.3 identifies protoporphyrin IX as a later product with fluorescent properties. The Introduction attributes porphyria-related photosensitivity to fluorescent porphyrins, supporting the description of PpIX as a photosensitizing agent. The supplied passages have no page numbers. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Heme biosynthesis ends in the mitochondrial matrix where ferrous iron (Fe2+) is inserted into the tetrapyrrole core of PpIX by ferrochelatase (FECH) to form heme [8].”
§ 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy > 2. ALA-Mediated PpIX Biosynthesis in the Heme Biosynthesis Pathway
What the sources say
- Supportedcites [8] Ajioka, 2006, Biosynthesis of Heme in Mammals, Biochim. Biophys. Acta (BBA)-Mol. Cell Res. source
The Introduction (page not provided) states that ferrochelatase resides in the mitochondrial matrix and catalyzes insertion of ferrous iron into the tetrapyrrole macrocycle of protoporphyrin IX to generate heme. Section 1.4 (page not provided) identifies this as the final step of heme biosynthesis. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The finding that enhanced PpIX biosynthesis can be induced by exogenously applied ALA in tumor cells has led to the use of ALA as a prodrug for PpIX-mediated photodynamic therapy (PDT) and photodiagnosis [5,6].”
§ 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy > 1. Introduction
What the sources say
- Supportedcites [5] Malik, 1987, Destruction of Erythroleukaemic Cells by Photoactivation of Endogenous Porphyrins, Br. J. Cancer source
The Summary (p. 589) reports that adding 5-ALA induced porphyrin biosynthesis in Friend erythroleukaemic cells, with protoporphyrin accumulating after eight days. This supports the claim that exogenous ALA can enhance PpIX production in tumor cells; the experiment itself was limited to that cell line. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [6] Kennedy, 1990, Photodynamic Therapy with Endogenous Protoporphyrin: IX: Basic Principles and Present Clinical Experience, J. Photochem. Photobiol. B Biol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
94 more claims · 29 with their cited sources checked
Create a free account to see all 159 claims and to verify the 29 references still open.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 56
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145 · cited 1×
“As a non-invasive therapeutic modality, PDT with various photosensitizers has been used in clinical settings for both cancerous and non-cancerous diseases [14].”
BackgroundStummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0005-8 · Cited by 1,866
Photodynamic therapy with endogenous protoporphyrin
Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(90)85083-9 · Cited by 1,509 · cited 20×
“Their pioneering work of applying ALA topically for stimulating local PpIX production followed by aimed Bioengineering 2023, 10, 496 5 of 23 light illumination for cell inactivation marked the beginning of future successes of ALAPDT for AK and superficial BCC, the most common precancerous and cancerous skin lesions, r…”
BackgroundInfluentialTargeting Autophagy in Cancer: Recent Advances and Future Directions
Amaravadi, R. K., Kimmelman, A. C., & Debnath, J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0292 · Cited by 928
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
Allen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 814
Walter, S., Susanne, S., Simon, W., Herbert, S., Clemens, F., Claudia, G., Alwin, E. G., Rainer, K., & Hans, J. R. (1998) · Neurosurgery · doi:10.1097/00006123-199803000-00017 · Cited by 690
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
Mao, Q., & Unadkat, J. D. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9668-6 · Cited by 670
The History of Photodetection and Photodynamic Therapy¶
Ackroyd, R., Kelty, C., Brown, N., & Reed, M. (2007) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2001)0740656thopap2.0.co2 · Cited by 667
5-Aminolevulinic Acid-Based Photodynamic Therapy: Principles and Experimental Research
Peng, Q., Berg, K., Moan, J., Kongshaug, M., & Nesland, J. M. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb08549.x · Cited by 615 · cited 1×
“Light activation of PpIX in mitochondria induces the formation of ROS species such as hydroxyl radicals, hydrogen peroxide, and superoxide radicals, which causes direct mitochondrial structural damage and Ca2+ release [24].”
BackgroundBiosynthesis of heme in mammals
Ajioka, R. S., Phillips, J. D., & Kushner, J. P. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.005 · Cited by 493
Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes
Chiabrando, D., Vinchi, F., Fiorito, V., Mercurio, S., & Tolosano, E. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00061 · Cited by 450
Symposium‐in‐Print: Singlet Oxygen Invited Review
Redmond, R. W., & Kochevar, I. E. (2006) · Photochemistry and Photobiology · doi:10.1562/2006-04-14-ir-874 · Cited by 421
Tetrapyrroles: the pigments of life
Battersby, A. R. (2000) · Natural Product Reports · doi:10.1039/b002635m · Cited by 414
A HISTORY OF PHOTODYNAMIC THERAPY
Daniell, M. D., & Hill, J. S. (1991) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1991.tb00230.x · Cited by 341
High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter
Özvegy-Laczka, C., Hegedűs, T., Várady, G., Ujhelly, O., Schuetz, J. D., Váradi, A., Kéri, G., Őrfi, L., Német, K., & Sarkadi, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1485 · Cited by 340
5-ALA and FDA Approval for Glioma Surgery
Hadjipanayis, C. G., & Stummer, W. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03098-y · Cited by 338
Cell death pathways: intricate connections and disease implications
Kist, M., & Vucic, D. (2021) · The EMBO Journal · doi:10.15252/embj.2020106700 · Cited by 321
Horbinski, C., Berger, T., Packer, R. J., & Wen, P. Y. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00679-w · Cited by 312
The biochemistry of heme biosynthesis
Heinemann, I. U., Jahn, M., & Jahn, D. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.015 · Cited by 311
Stenzl, A., Burger, M., Fradet, Y., Mynderse, L. A., Soloway, M. S., Witjes, J. A., Kriegmair, M., Karl, A., Shen, Y., & Grossman, H. B. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.06.148 · Cited by 304
Grossman, H. B., Gomella, L., Fradet, Y., Morales, A., Presti, J., Ritenour, C., Nseyo, U., Droller, M. J., & PC B302/01 Study Group (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.034 · Cited by 300
Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins
Malik, Z., & Lugaci, H. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.246 · Cited by 292
Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.
Gaullier, J., Berg, K., Peng, Q., Anholt, H., Selbo, P. K., Ma, L. W., & Moan, J. E. (1997) · PubMed · Cited by 287
Stummer, W., Stepp, H., Möller, G., Ehrhardt, A., Leonhard, M., & Reulen, H. J. (1998) · Acta Neurochirurgica · doi:10.1007/s007010050206 · Cited by 281
Kriegmair, M., Ehsan, A., Baumgartner, R., Lumper, W., Knuechel, R., Hofstädter, F., Steinbach, P., & Hofstetter, A. (1994) · Urology · doi:10.1016/s0090-4295(94)80167-3 · Cited by 265
A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin
Iinuma, S., Farshi, S., Ortel, B., & Hasan, T. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.244 · Cited by 240
5‐ALA in the management of malignant glioma
Stepp, H., & Stummer, W. (2018) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22933 · Cited by 234 · cited 1×
“With the insertion of paramagnetic iron into PpIX, heme possesses neither fluorescence nor photosensitizing activity [9].”
BackgroundHistory of Photodynamic Therapy
Abdel-Kader, M. H. (2014) · Photodynamic Therapy · doi:10.1007/978-3-642-39629-8_1 · Cited by 231
Uehlinger, P., Zellweger, M., Wagnières, G., Juillerat-Jeanneret, L., van den Bergh, H., & Lange, N. (2000) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(99)00159-1 · Cited by 221 · cited 1×
“Since topically applied ALA has slow and limited tissue penetration due to its hydrophilicity, hexaminolevulinate (HAL) with increased lipophilicity was developed to overcome these limitations [59].”
BackgroundPeng, Q., Soler, A. M., Warloe, T., Nesland, J. M., & Giercksky, K.-E. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00173-7 · Cited by 218
ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy
Robey, R. W., Steadman, K., Polgar, O., & Bates, S. E. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1440 · Cited by 204
Fritsch, C., Homey, B., Stahl, W., Lehmann, P., Ruzicka, T., & Sies, H. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb02492.x · Cited by 192
Gomes Marin, J. F., Nunes, R. F., Coutinho, A. M., Zaniboni, E. C., Costa, L. B., Barbosa, F. G., Queiroz, M. A., Cerri, G. G., & Buchpiguel, C. A. (2020) · RadioGraphics · doi:10.1148/rg.2020200021 · Cited by 190
PONKA, P. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199910000-00004 · Cited by 182
DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
Peng, Q., Warloe, T., Moan, J., Heyerdahl, H., Steen, H. B., Nesland, J. M., & Giercksky, K. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb09154.x · Cited by 178
Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX
Noodt, B., Berg, K., Stokke, T., Peng, Q., & Nesland, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.310 · Cited by 174 · cited 1×
“While some cell lines undergo rapid apoptotic cell death within hours of PDT, others are more prone to die by necrosis at later times [30].”
BackgroundBisland, S. K., Lilge, L., Lin, A., Rusnov, R., & Wilson, B. C. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-03-05-ra-100.1 · Cited by 173 · cited 1×
“The dose of ALA and light as well as the light dose (fluence) rate may also determine how cells die of PDT, with low-dose PDT often inducing apoptosis and high-dose PDT typically resulting in necrosis [32,33].”
BackgroundTeng, L., Nakada, M., Zhao, S.-G., Endo, Y., Furuyama, N., Nambu, E., Pyko, I. V., Hayashi, Y., & Hamada, J.-I. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.12 · Cited by 172
Casas, A. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.008 · Cited by 164
Yang, X., Palasuberniam, P., Kraus, D., & Chen, B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025865 · Cited by 158
Self-citationZhou, S., Zong, Y., Ney, P. A., Nair, G., Stewart, C. F., & Sorrentino, B. P. (2005) · Blood · doi:10.1182/blood-2004-04-1566 · Cited by 157
Transport of 5-aminolevulinic acid between blood and brain
Ennis, S. R., Novotny, A., Xiang, J., Shakui, P., Masada, T., Stummer, W., Smith, D. E., & Keep, R. F. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03749-6 · Cited by 146
Berg, K., Anholt, H., Bech, Ø., & Moan, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.423 · Cited by 142
The Inhibitor Ko143 Is Not Specific for ABCG2
Weidner, L. D., Zoghbi, S. S., Lu, S., Shukla, S., Ambudkar, S. V., Pike, V. W., Mulder, J., Gottesman, M. M., Innis, R. B., & Hall, M. D. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225482 · Cited by 141
Malik, Z., Kostenich, G., Roitman, L., Ehrenberg, B., & Orenstein, A. (1995) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(95)07117-k · Cited by 138
Kobuchi, H., Moriya, K., Ogino, T., Fujita, H., Inoue, K., Shuin, T., Yasuda, T., Utsumi, K., & Utsumi, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050082 · Cited by 137
Liu, W., Baer, M. R., Bowman, M. J., Pera, P., Zheng, X., Morgan, J., Pandey, R. A., & Oseroff, A. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1599 · Cited by 136
Koenig, F., McGovern, F. J., Larne, R., Enquist, H., Schomacker, K. T., & Deutsch, T. F. (1999) · BJU International · doi:10.1046/j.1464-410x.1999.00917.x · Cited by 129 · cited 1×
“A following clinical trial demonstrated that ALA-based fluorescence cystoscopy resulted in an 18% higher diagnosis of bladder cancer than the standard white light cystoscopy, particularly dysplastic lesions and carcinoma in situ (CIS) that are superficial and flat, therefore, showing a similar appearance to the surrou…”
BackgroundMARTI, A., JICHLINSKI, P., LANGE, N., BALLINI, J.-P., GUILLOU, L., LEISINGER, H. J., & KUCERA, P. (2003) · Journal of Urology · doi:10.1097/01.ju.0000075054.38441.2d · Cited by 129
Rittenhouse‐Diakun, K., Leengoed, H. V., Morgan, J., Hryhorenko, E., Paszkiewicz, G., Whitaker, J. E., & Oseroff, A. R. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb02356.x · Cited by 124
Schipmann, S., Müther, M., Stögbauer, L., Zimmer, S., Brokinkel, B., Holling, M., Grauer, O., Suero Molina, E., Warneke, N., & Stummer, W. (2021) · Journal of Neurosurgery · doi:10.3171/2019.11.jns192443 · Cited by 121
de Haas, E. R. M., Kruijt, B., Sterenborg, H. J. C. M., Martino Neumann, H. A., & Robinson, D. J. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700460 · Cited by 118
Silencing of human ferrochelatase causes abundant protoporphyrin‐IX accumulation in colon cancer
Kemmner, W., Wan, K., Rüttinger, S., Ebert, B., Macdonald, R., Klamm, U., & Moesta, K. T. (2008) · The FASEB Journal · doi:10.1096/fj.07-8888com · Cited by 114
Hanania, J., & Malik, Z. (1992) · Cancer Letters · doi:10.1016/0304-3835(92)90156-p · Cited by 113
Grebeňová, D., Kuželová, K., Smetana, K., Pluskalová, M., Cajthamlová, H., Marinov, I., Fuchs, O., Souček, J., Jarolı́m, P., & Hrkal, Z. (2003) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(02)00410-4 · Cited by 107
Anand, S., Wilson, C., Hasan, T., & Maytin, E. V. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0805 · Cited by 95
Eatz, T. A., Eichberg, D. G., Lu, V. M., Di, L., Komotar, R. J., & Ivan, M. E. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03901-9 · Cited by 93 · cited 1×
“However, due to the invasive growth of high-grade glioma cells and the similarity in appearance between tumor and surrounding normal tissues, glioma surgery under conventional white light illumination often leaves behind viable tumor tissue, resulting in subsequent disease recurrence [46].”
BackgroundStimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells
Wang, X., Ji, J., Zhang, H., Fan, Z., Zhang, L., Shi, L., Zhou, F., Chen, W. R., Wang, H., & Wang, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5975 · Cited by 92
5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma
Coupienne, I., Fettweis, G., Rubio, N., Agostinis, P., & Piette, J. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05213f · Cited by 91
Photodynamic Therapy: From Theory to Application
Abdel‐Kader, M. H. (2014) · Springer eBooks · doi:10.1007/978-3-642-39629-8 · Cited by 90
Vijlder, H., Sterenborg, H., Neumann, H., Robinson, D., & Haas, E. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1448 · Cited by 89
Palasuberniam, P., Yang, X., Kraus, D., Jones, P., Myers, K. A., & Chen, B. (2015) · Scientific Reports · doi:10.1038/srep13298 · Cited by 89
Self-citationBhowmick, R., & Girotti, A. W. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.040 · Cited by 84
Coupienne, I., Bontems, S., Dewaele, M., Rubio, N., Habraken, Y., Fulda, S., Agostinis, P., & Piette, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.015 · Cited by 83
Maisch, T., Santarelli, F., Schreml, S., Babilas, P., & Szeimies, R. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01001.x · Cited by 83
Etminan, N., Peters, C., Lakbir, D., Bünemann, E., Börger, V, Sabel, M. C., Hänggi, D., Steiger, H.-J., Stummer, W., & Sorg, R. V. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.327 · Cited by 79
Miyake, M., Ishii, M., Kawashima, K., Kodama, T., Sugano, K., Fujimoto, K., & Hirao, Y. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00543.x · Cited by 79
Topical Aminolevulinic Acid HCl Photodynamic Therapy
Ormrod, D., & Jarvis, B. (2000) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200001020-00009 · Cited by 79
Fahey, J. M., & Girotti, A. W. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.05.006 · Cited by 77
Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells
Ogino, T., Kobuchi, H., Munetomo, K., Fujita, H., Yamamoto, M., Utsumi, T., Inoue, K., Shuin, T., Sasaki, J., Inoue, M., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0980-5 · Cited by 77
Sun, W. Y., Kajimoto, Y., Inoue, H., Miyatake, S., Ishikawa, T., & Kuroiwa, T. (2012) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2012.06.003 · Cited by 71
Curnow, A., Mcllroy, B., Postle-Hacon, M., Porter, J., MacRobert, A., & Bown, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.671 · Cited by 68
Visualization technologies for 5-ALA-based fluorescence-guided surgeries
Wei, L., Roberts, D. W., Sanai, N., & Liu, J. T. C. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03077-9 · Cited by 67 · cited 1×
“Probe-based sectioning microscopes with red light illumination are able to provide high-resolution quantitative imaging of PpIX even in deep tissues [81].”
BackgroundBhowmick, R., & Girotti, A. W. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.12.005 · Cited by 67
Furre, I. E., Møller, M. T. N., Shahzidi, S., Nesland, J. M., & Peng, Q. (2006) · Apoptosis · doi:10.1007/s10495-006-0190-x · Cited by 66 · cited 1×
“Indeed, PDT with hexaminolevulinate has been shown to induce apoptosis via both caspase-dependent and -independent pathways [29].”
BackgroundJaber, M., Ewelt, C., Wölfer, J., Brokinkel, B., Thomas, C., Hasselblatt, M., Grauer, O., & Stummer, W. (2019) · Neurosurgery · doi:10.1093/neuros/nyy365 · Cited by 66
Choudry, K., Brooke, R. C. C., Farrar, W., & Rhodes, L. E. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05351.x · Cited by 65
Bhowmick, R., & Girotti, A. W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.09.025 · Cited by 65
Inoue, K., Karashima, T., Kamada, M., Shuin, T., Kurabayashi, A., Furihata, M., Fujita, H., Utsumi, K., & Sasaki, J. (2009) · Pathobiology · doi:10.1159/000245896 · Cited by 64
Fukuhara, H., Inoue, K., Kurabayashi, A., Furihata, M., Fujita, H., Utsumi, K., Sasaki, J., & Shuin, T. (2013) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2013.03.003 · Cited by 60
Schupper, A. J., Baron, R. B., Cheung, W., Rodriguez, J., Kalkanis, S. N., Chohan, M. O., Andersen, B. J., Chamoun, R., Nahed, B. V., Zacharia, B. E., et al. (2022) · Journal of Neurosurgery · doi:10.3171/2021.5.jns21310 · Cited by 59
Fahey, J. M., Stancill, J. S., Smith, B. C., & Girotti, A. W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000443 · Cited by 59
Kriska, T., Korytowski, W., & Girotti, A. W. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01078-x · Cited by 59
Sun, Z., Zhao, M., Wang, W., Hong, L., Wu, Z., Luo, G., Lu, S., Tang, Y., Li, J., Wang, J., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2022.216032 · Cited by 57
Kaneko, S., Suero Molina, E., Ewelt, C., Warneke, N., & Stummer, W. (2019) · Neurosurgery · doi:10.1093/neuros/nyz129 · Cited by 56 · cited 2×
“patients indicates the maximum fluorescence at 7–8 h [70].”
BackgroundKitajima, Y., Ishii, T., Kohda, T., Ishizuka, M., Yamazaki, K., Nishimura, Y., Tanaka, T., Dan, S., & Nakajima, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-44981-y · Cited by 56
Maytin, E. V., Kaw, U., Ilyas, M., Mack, J. A., & Hu, B. (2018) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2018.02.009 · Cited by 55
Yang, X., Li, W., Palasuberniam, P., Myers, K. A., Wang, C., & Chen, B. (2015) · Photochemistry and Photobiology · doi:10.1111/php.12454 · Cited by 55
Self-citationZeng, Q., Yang, J., Ji, J., Wang, P., Zhang, L., Yan, G., Wu, Y., Chen, Q., Liu, J., Zhang, G., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2061396 · Cited by 54
Topical photodynamic therapy is immunosuppressive in humans: PDT is immunosuppressive in humans
Matthews, Y. J., & Damian, D. L. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09562.x · Cited by 54
Bravo, J. J., Olson, J. D., Davis, S. C., Roberts, D. W., Paulsen, K. D., & Kanick, S. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-09727-8 · Cited by 53
Kaw, U., Ilyas, M., Bullock, T., Rittwage, L., Riha, M., Vidimos, A., Hu, B., Warren, C. B., & Maytin, E. V. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.09.010 · Cited by 53 · cited 1×
“Furthermore, blue light illumination immediately after ALA application results in significantly less pain, without losing much efficacy evaluated at 3 months after treatment, than the conv ntional protocol where ALA is applied hours before gh treatmen [64].”
Backgroundde Souza, A. L. R., Marra, K., Gunn, J., Samkoe, K. S., Kanick, S. C., Davis, S. C., Chapman, M. S., Maytin, E. V., Hasan, T., & Pogue, B. W. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.267 · Cited by 51
The Hydroxypyridinone Iron Chelator CP94 Can Enhance PpIX‐induced PDT of Cultured Human Glioma Cells
Blake, E., & Curnow, A. (2010) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2010.00770.x · Cited by 51
Inoue, H., Kajimoto, Y., Shibata, M.-A., Miyoshi, N., Ogawa, N., Miyatake, S.-I., Otsuki, Y., & Kuroiwa, T. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9325-8 · Cited by 50
Gadmar, Ø. B., Phillips, D., Moan, J. E., & MacRobert, A. J. (1997) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(97)00095-x · Cited by 50
ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells
Müller, P., Abdel Gaber, S. A., Zimmermann, W., Wittig, R., & Stepp, H. (2020) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2020.111963 · Cited by 49
Chang, S.-C., MacRobert, A. J., Porter, J. B., & Brown, S. G. (1997) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(96)07441-6 · Cited by 49 · cited 1×
“ALA in combination with CP94 induces significantly higher PpIX fluorescence than ALA alone in rat bladder urothelium [96] and colonic mucosa [97].”
BackgroundAntagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model
Fahey, J. M., Emmer, J. V., Korytowski, W., Hogg, N., & Girotti, A. W. (2016) · Photochemistry and Photobiology · doi:10.1111/php.12636 · Cited by 49
Valdés, P. A., Samkoe, K., O’Hara, J. A., Roberts, D. W., Paulsen, K. D., & Pogue, B. W. (2010) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00664.x · Cited by 48
Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid
HAYAMI, J., OKAMOTO, H., SUGIHARA, A., & HORIO, T. (2007) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2007.00280.x · Cited by 46
A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis
Reinhold, U. (2017) · Future Oncology · doi:10.2217/fon-2017-0247 · Cited by 46
Black, D., Kaneko, S., Walke, A., König, S., Stummer, W., & Suero Molina, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-99228-6 · Cited by 46 · cited 1×
“Although most high-grade gliomas show strong PpIX fluorescence, low-grade gliomas typically do not exhibit PpIX fluorescence [50,51].”
BackgroundPye, A., & Curnow, A. (2007) · Photochemistry and Photobiology · doi:10.1562/2006-05-30-ra-906 · Cited by 45 · cited 2×
“It turns out that the effects of iron chelators on ALA-PpIX fluorescence are highly dependent on the cell line and ALA dose [85,88,92,105].”
BackgroundSotiriou, E., Apalla, Z., Chovarda, E., Goussi, C., Trigoni, A., & Ioannides, D. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04003.x · Cited by 44
Grandi, V., Bacci, S., Corsi, A., Sessa, M., Puliti, E., Murciano, N., Scavone, F., Cappugi, P., & Pimpinelli, N. (2018) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2017.12.012 · Cited by 42
Coupienne, I., Fettweis, G., & Piette, J. (2011) · Lasers in Surgery and Medicine · doi:10.1002/lsm.21088 · Cited by 41
Differential Sensitivity in Cell Lines to Photodynamic Therapy in Combination with ABCG2 Inhibition
Barron, G. A., Moseley, H., & Woods, J. A. (2013) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2013.07.003 · Cited by 40
Erkkilä, M. T., Bauer, B., Hecker‐Denschlag, N., Madera Medina, M. J., Leitgeb, R. A., Unterhuber, A., Gesperger, J., Roetzer, T., Hauger, C., Drexler, W., et al. (2019) · Journal of Biophotonics · doi:10.1002/jbio.201800378 · Cited by 39
Metabolism of KO143, an ABCG2 inhibitor
Liu, K., Zhu, J., Huang, Y., Li, C., Lu, J., Sachar, M., Li, S., & Ma, X. (2017) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2017.02.003 · Cited by 39
Mansi, M., Howley, R., Chandratre, S., & Chen, B. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115031 · Cited by 38
Self-citationFahey, J. M., Korytowski, W., & Girotti, A. W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.013 · Cited by 38
Optimizing maximum resection of glioblastoma: Raman spectroscopy versus 5-aminolevulinic acid
Herta, J., Cho, A., Roetzer-Pejrimovsky, T., Höftberger, R., Marik, W., Kronreif, G., Peilnsteiner, T., Rössler, K., & Wolfsberger, S. (2022) · Journal of neurosurgery · doi:10.3171/2022.11.jns22693 · Cited by 37
Hryhorenko, E. A., Rittenhouse-Diakun, K., Harvey, N. S., Morgan, J., Stewart, C. C., & Oseroff, A. R. (1998) · PubMed · Cited by 35
(2001) · PubMed · Cited by 33
Blake, E., Allen, J., & Curnow, A. (2011) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2011.00985.x · Cited by 33
Hosmann, A., Millesi, M., Wadiura, L. I., Kiesel, B., Mercea, P. A., Mischkulnig, M., Borkovec, M., Furtner, J., Roetzer, T., Wolfsberger, S., et al. (2021) · Cancers · doi:10.3390/cancers13112540 · Cited by 33
Suero Molina, E., Stögbauer, L., Jeibmann, A., Warneke, N., & Stummer, W. (2020) · Acta Neurochirurgica · doi:10.1007/s00701-020-04227-7 · Cited by 33
Ge, X., Liu, J., Shi, Z., Jing, L., Yu, N., Zhang, X., Jiao, Y., Wang, Y., & Li, P. A. (2016) · European Journal of Dermatology · doi:10.1684/ejd.2015.2725 · Cited by 32
Pye, A., Campbell, S., & Curnow, A. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0358-6 · Cited by 32 · cited 1×
“Moreover, a small pilot clinical trial has demonstrated the safety and efficacy of combining MAL and CP94 for BCC treatment [98].”
Backgroundde Bruijn, H. S., Casas, A. G., Di Venosa, G., Gandara, L., Sterenborg, H. J. C. M., Batlle, A., & Robinson, D. J. (2013) · Photochemical & Photobiological Sciences · doi:10.1039/c2pp25287b · Cited by 31
Hryhorenko, E. A., Rittenhouse-Diakun, K., Harvey, N. S., Morgan, J., Stewart, C. C., & Oseroff, A. R. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb09456.x · Cited by 31
Enhancement of photodynamic therapy in gastric cancer cells by removal of iron.
Tan, W. C., Krasner, N., O'Toole, P., & Lombard, M. (1997) · Gut · doi:10.1136/gut.41.1.14 · Cited by 31
Daylight-PDT: Everything under the Sun
Beiki, D., Eggleston, I. M., & Pourzand, C. (2022) · Biochemical Society Transactions · doi:10.1042/bst20200822 · Cited by 31
Hryhorenko, E. A., Oseroff, A. R., Morgan, J., & Rittenhouse-Diakun, K. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00047-2 · Cited by 30
Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma
Kaneko, S., Suero Molina, E., Sporns, P., Schipmann, S., Black, D., & Stummer, W. (2022) · Journal of Neurosurgery · doi:10.3171/2020.10.jns202881 · Cited by 28
Specific Inhibition of the ABCG2 Transporter Could Improve the Efficacy of Photodynamic Therapy
Bebes, A., Nagy, T., Bata-Csörgő, Z., Kemény, L., Dobozy, A., & Széll, M. (2011) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2011.08.007 · Cited by 28
Suero Molina, E., Black, D., Kaneko, S., Müther, M., & Stummer, W. (2022) · Journal of Neurosurgery · doi:10.3171/2021.12.jns211724 · Cited by 28 · cited 2×
“This notion is supported by the finding that doubling the dose of ALA from 20 to 40 mg/kg not only significantly increases tumor PpIX fluorescence but also doubles the rate of tumor detection in low-grade glioma patients [55].”
BackgroundYang, J., Xia, Y., Liu, X., Jiang, S., & Xiong, L. (2010) · Lasers in Medical Science · doi:10.1007/s10103-009-0721-0 · Cited by 28
Evangelou, G., Farrar, M. D., White, R. D., Sorefan, N. B., Wright, K. P., McLean, K., Andrew, S., Watson, R. E. B., & Rhodes, L. E. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10433.x · Cited by 27
Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy
Girotti, A. W., & Fahey, J. M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113750 · Cited by 26
RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death
Fettweis, G., Di Valentin, E., L'homme, L., Lassence, C., Dequiedt, F., Fillet, M., Coupienne, I., & Piette, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.10.014 · Cited by 26
Evangelou, G., Farrar, M. D., Cotterell, L., Andrew, S., Tosca, A. D., Watson, R. E. B., & Rhodes, L. E. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10823.x · Cited by 25
Howley, R., Mansi, M., Shinde, J., Restrepo, J., & Chen, B. (2020) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2020.112017 · Cited by 25
Self-citationProtoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization
Piffaretti, D., Burgio, F., Thelen, M., Kaelin-Lang, A., Paganetti, P., Reinert, M., & D'Angelo, M. L. (2019) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2019.111640 · Cited by 24
Topical Methyl Aminolevulinate
Siddiqui, M. A. A., Perry, C. M., & Scott, L. J. (2004) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200405020-00006 · Cited by 24 · cited 1×
“PDT with this MAL protocol and red light illumination (with deeper tissue penetration than blue light) showed up to 91% and 97% complete responses in AK and BCC lesions, respectively, in randomized multicenter phase III clinical trials [21].”
MethodHow to Avoid Local Side Effects of Bladder Photodynamic Therapy: Impact of the Fluence Rate
François, A., Salvadori, A., Bressenot, A., Bezdetnaya, L., Guillemin, F., & D'Hallewin, M. A. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.01.046 · Cited by 23
Zhou, B.-R., Zhang, L.-C., Permatasari, F., Liu, J., Xu, Y., & Luo, D. (2016) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2016.02.005 · Cited by 23
Palasuberniam, P., Kraus, D., Mansi, M., Braun, A., Howley, R., Myers, K. A., & Chen, B. (2019) · Photochemistry and Photobiology · doi:10.1111/php.13091 · Cited by 23
Self-citationZeng, L., Zou, Q., Huang, P., Xiong, L., Cheng, Y., Chen, Q., Li, Y., He, H., Yi, W., & Wei, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111994 · Cited by 23
Curnow, A., Perry, A., & Wood, M. (2019) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2018.12.005 · Cited by 22
Quantitative Modulation of PpIX Fluorescence and Improved Glioma Visualization
Reinert, M., Piffaretti, D., Wilzbach, M., Hauger, C., Guckler, R., Marchi, F., & D'Angelo, M. L. (2019) · Frontiers in Surgery · doi:10.3389/fsurg.2019.00041 · Cited by 22
In vivo tumor imaging using a novel RNAi-based detection mechanism
Wan, K., Ebert, B., Voigt, J., Wang, Q., Dai, Y., Haag, R., & Kemmner, W. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.02.004 · Cited by 21
Miao, F., Lv, T., Zhang, Y., Huang, Z., Wang, X., & Wang, H. (2016) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2015.07.004 · Cited by 20
Bai-Habelski, J. C., Medrano, K., Palacio, A., & Reinhold, U. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102692 · Cited by 20
Adamek, M., Kawczyk-Krupka, A., Mostowy, A., Czuba, Z., Krol, W., Kasperczyk, S., Jakobisiak, M., Golab, J., & Sieron, A. (2005) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00004-9 · Cited by 19
Sassa, S., Schwartz, S., & Ruth, G. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.5.1094 · Cited by 19 · cited 1×
“ALA was known to cause endogenous PpIX accumulation in human lymphocytes in the 1970s [15].”
BackgroundAnayo, L., Magnussen, A., Perry, A., Wood, M., & Curnow, A. (2018) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22809 · Cited by 19 · cited 1×
“A drug conjugate called AP2-18 that links ALA to CP94 through a cleavable ester bond has been developed in order to release both agents simultaneously following the cleavage by esterases [99].”
BackgroundMolina, E. S., Ewelt, C., Warneke, N., Schwake, M., Müther, M., Schipmann, S., & Stummer, W. (2019) · Journal of neurosurgery · doi:10.3171/2018.12.jns182422 · Cited by 18
Bunk, E. C., Wagner, A., Stummer, W., Senner, V., & Brokinkel, B. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03680-9 · Cited by 18
Qin, J., Zhou, C., Zhu, M., Shi, S., Zhang, L., Zhao, Y., Li, C., Wang, Y., & Wang, Y. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101907 · Cited by 17
(2004) · PubMed · Cited by 17
Darvekar, S., Juzenas, P., Oksvold, M., Kleinauskas, A., Holien, T., Christensen, E., Stokke, T., Sioud, M., & Peng, Q. (2020) · Cancers · doi:10.3390/cancers12020377 · Cited by 16
Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC
Lv, T., Huang, J., Wu, M., Wang, H., Zeng, Q., & Wang, X. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102572 · Cited by 16
Molina, E. S., Hellwig, S. J., Walke, A., Jeibmann, A., Stepp, H. G., & Stummer, W. (2022) · Journal of neurosurgery · doi:10.3171/2021.10.jns211911 · Cited by 16
Palasuberniam, P., Kraus, D., Mansi, M. S., Howley, R., Braun, A., Myers, K. A., & Chen, B. (2021) · Journal of Biomedical Optics · doi:10.1117/1.jbo.26.9.098002 · Cited by 16
Self-citationStrickland, B. A., Wedemeyer, M., Ruzevick, J., Micko, A., Shahrestani, S., Daneshmand, S., Shiroishi, M. S., Hwang, D. H., Attenello, F., Chen, T., et al. (2022) · Journal of Neurosurgery · doi:10.3171/2022.1.jns212562 · Cited by 15
Zhang, X., Cai, L., He, J., Li, X., Li, L., Chen, X., & Lan, P. (2017) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2017.08.004 · Cited by 14
Wirth, D. J., Sibai, M., Wilson, B. C., Roberts, D. W., & Paulsen, K. (2020) · Biomedical Optics Express · doi:10.1364/boe.397507 · Cited by 14
Kaneko, S., Brokinkel, B., Suero Molina, E., Warneke, N., Holling, M., Bunk, E. C., Hess, K., Senner, V., Paulus, W., & Stummer, W. (2020) · Acta Neurochirurgica · doi:10.1007/s00701-020-04353-2 · Cited by 13
Magnussen, A., Reburn, C., Perry, A., Wood, M., & Curnow, A. (2022) · Lasers in Medical Science · doi:10.1007/s10103-021-03367-1 · Cited by 11
Christensen, E., Foss, O. A., Quist-Paulsen, P., Staur, I., Pettersen, F., Holien, T., Juzenas, P., & Peng, Q. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101558 · Cited by 10
Fang, S., Wu, Y., Zhang, H., Zeng, Q., Wang, P., Zhang, L., Yan, G., Zhang, G., & Wang, X. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.102907 · Cited by 10
Howley, R., Mansi, M., Shinde, J., Restrepo, J., & Chen, B. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13678 · Cited by 8
Self-citation(1979) · PubMed · Cited by 6
Sensitized Photooxidation of Di- and Tripeptides of Tyrosine
Criado, S., Soltermann, A. T., Marioli, J. M., & Garcı́a, N. A. (1998) · Photochemistry and Photobiology · doi:10.1562/0031-8655(1998)068<0088:eosubr>2.3.co;2 · Cited by 2
Cited by
NIR-activated multifunctional agents for the combined application in cancer imaging and therapy
Repetowski, P., Warszyńska, M., & Dąbrowski, J. M. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103356 · Cited by 48
Enhancing 5-ALA-PDT efficacy against resistant tumor cells: Strategies and advances
Ebrahimi, S., Ghadiri, M. K., Stummer, W., & Gorji, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122808 · Cited by 39
Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review
Bartusik‐Aebisher, D., Woźnicki, P., Dynarowicz, K., & Aebisher, D. (2023) · Brain Sciences · doi:10.3390/brainsci13091299 · Cited by 38
“Research was also undertaken on the combination of m -THPC with gold nanoparticles (AuNPs), and it was observed that under the influence of laser radiation of the PDT/PTT combination, phototoxicity was twice as high as compared to treatment with only PDT or only PTT [73].”
MethodChandratre, S., Olsen, J., Howley, R., & Chen, B. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115851 · Cited by 35
Self-citationDing, Q., Zhou, L., Xiong, T., Liu, J., Chen, L., Yoo, J., Xu, X., Jia, X., Chen, S., Chen, S., et al. (2025) · National Science Review · doi:10.1093/nsr/nwaf554 · Cited by 41
Metadata
- Authors
- Howley, R., Chandratre, S., & Chen, B.
- Affiliations
- Saint Joseph's University (US)
- Corresponding author
- Chen, Bin
- ORCID
- Howley, Richard
- Venue
- Bioengineering
- Publisher
- MDPI AG
- Published
- 2023-04-21
- Volume
- 10
- Issue
- 4
- Pages
- 496
- ISSN
- 2306-5354 (ISSN-L)
- PMC
- PMC10136048
- OpenAlex
- W4366775638
- Cited by
- 33
- References
- 180
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 15 · 2023: 3
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Bioengineering (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- NIH (R15CA268200)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Materials Chemistry › Porphyrin and Phthalocyanine Chemistry
- Keywords
- 5-aminolevulinic acid, protoporphyrin IX, heme biosynthesis, photodynamic therapy, theranostics, photosensitizers, actinic keratosis, basal cell carcinoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.